NEUTRA CORP.

NTRR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016
Revenue $68.0K $92.0K $9.7K $6.4K
Cost of Revenue $32.7K $60.9K $42.9K
Gross Profit $35.3K $31.2K $-33.3K $6.4K
Gross Margin 51.9% 33.9% -343.3% 100.0%
Operating Expenses
Research & Development
SG&A Expense $228.0K $508.5K $414.7K $400.6K $1.7M $163.7K $370.7K $1.0M
Operating Income $-297.7K $-583.6K $-478.7K $-394.2K $-1.7M $-163.7K $-370.7K $-1.0M
Operating Margin -437.8% -634.2% -4,941.3% -6,164.9%
Interest Expense $62.1K $60.6K $121.6K $340.7K $720.8K $355.3K $497.2K $401.6K
Pretax Income $-557.9K $-632.9K
Income Tax Expense $3.5K $3.5K $0
Net Income $-561.4K $-632.9K $-538.9K $-695.6K $-2.4M $-519.0K $-867.9K $-1.4M
Net Margin -825.7% -687.9% -5,563.0% -10,877.6%
EPS (Basic) $0.00 $0.00 $-0.16 $-0.10 $-0.41 $-1.25
EPS (Diluted) $0.00 $0.00 $-0.16 $-0.10 $-0.41 $-1.25
Shares Outstanding (Basic) 2.92B 2.21B 1.52B 1.38B 40.5M 6.8M 4.3M 1.9M
Shares Outstanding (Diluted) 2.92B 2.21B 1.52B 1.38B 40.5M 6.8M 4.3M 1.9M
Dividends Per Share
← Newer Page 1 of 2 Older →